Xufen Yu

22PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersMedical devicesMolecular targetsInjury preventionHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 14, 2026
An EZH2-SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis.

|Jul 08, 2026
RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1.

|Jun 17, 2026
Unique Cysteine-Directed Covalent Inhibition of PRMT1 Suppresses Breast Tumorigenesis.

|May 13, 2026
Targeted Degradation of Prolyl Hydroxylase Domain Enzyme 1 (PHD1) as a Novel Therapeutic Strategy for Acetaminophen-Induced Acute Liver Injury.

|Apr 17, 2026
ELMO2 is a therapeutic vulnerability in mesenchymal-like and drug-resistant non-small cell lung cancer.

|Mar 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

Yang Yi, Yanqiang Li, Rui Wang

Pageof 4

Frequent Collaborators

18 joint publications

Jian Jin

6 joint publications

Gang Greg Wang

5 joint publications

H Ümit Kaniskan

2 joint publications

Jithesh Kottur